Advancing Patient Care Through Pharma-Sponsored Programs

Community pharmacies navigate an increasingly complex health care ecosystem where patient care often stalls after prescriptions are written. When pharmacies display buy-in with the community programs their patients need most, financial viability within an independent business becomes a more easily executable task.

At the Total Pharmacy Solutions Summit Fall 2026 event, Dorrit Trate, MHA, SVP of Pharma Solutions at Outcomes, presented on the strategies to bridge care gaps through targeted pharmaceutical manufacturer programs. Drawing from her extensive background across health systems, patient education platforms, and health care technologies, Trate outlined how industry collaboration can streamline operations and improve patient outcomes.

Her presentation highlights actionable approaches for community pharmacists seeking to reduce administrative friction and foster patient loyalty within their practice. Aligning pharmacy workflows with manufacturer resources allows teams to keep patients centered throughout their treatment journeys.

Navigating modern medical care presents substantial hurdles for both patients and providers. Patients face non-linear treatment paths complicated by scheduling conflicts, transportation barriers, and financial burdens. Meanwhile, primary care physicians operate under extreme time constraints, spending up to 45% of their daily working hours on documentation.

Without clinical support, a physician managing 2500 patients would require more than 26 hours a day to deliver optimal care. Although 75% of consumers initiate treatment discussions after viewing brand advertising, long-term success depends on consistent support after patients leave the clinical environment.

Unintended prescription abandonment represents a primary operational and clinical challenge for pharmacy staff. An Outcomes data analysis examining 1.3 million first-fill prescriptions across 5000 network pharmacies revealed significant bottlenecks. Approximately 28% of initial fills encountered immediate insurance rejections or required prior authorizations before processing.

An additional 18% of claims were placed on hold without specific rejection codes. Within a 90-day window, only 15% of these held prescriptions were ultimately filled, leaving 38% of initial prescriptions completely unfilled and forcing staff to perform unnecessary return-to-stock procedures.

Leveraging Automated Digital Solutions for Prescription Retention

To address these workflow disruptions, Outcomes partners with pharmaceutical manufacturers to deliver automated, text-based educational programs directly to patients. These digital messaging campaigns automatically engage individuals at key intervention points, including first-fill processing, refill reminders, and dose escalation steps.

When prior authorization hurdles arise, text messaging keeps patients informed about resolution progress to prevent premature prescription abandonment. Brief digital surveys allow pharmacies to identify specific barriers such as cost or transportation, giving manufacturers real-time intelligence to refine patient assistance resources.

These automated communications execute in the background without adding manual burdens to busy pharmacy teams.

Peer-reviewed clinical research published in JAMA underscores the efficacy of digital communication in driving patient behavior. Studies show that digital engagement doubles the likelihood of a patient completing an initial prescription fill and generates a 25% lift in refills when sending multiple yet timely reminders. Real-world metrics from Outcomes programs reflect similar success.

In a multi-brand diabetes case study involving 4 major manufacturers, digital messaging yielded a 10% overall increase in prescription fills compared with control groups. Top-performing brand campaigns within the network achieved up to a 55% incremental boost in script fills alongside click-through rates reaching 62.5%.

Driving Dual Revenue Streams and Strengthening Network Reach

Participating in manufacturer-sponsored digital programs offers substantial economic and operational advantages for independent and retail pharmacies. By elevating prescription adherence, pharmacies capture incremental fill revenue while receiving direct financial support for program participation.

Managing these initiatives through a centralized platform connects over 5000 independent pharmacies, alongside national retail partners, with major life science brands through a single integration point. This unified structure allows community practices to deliver high-touch patient support while optimizing overall business performance.

Pharmacists interested in transforming prescription abandonments into sustainable patient relationships can explore the full presentation on-demand.

Explore more of our coverage from the Total Pharmacy Solutions Summit Fall 2026: Patient First.